Researchers at the University of Pennsylvania School of Medicine have discovered that a protein called FOXA2 controls genes that maintain the proper level of bile in the liver. FOXA2 may become the focus for new therapies to treat diseases that involve the regulation of bile salts. The study was published online this week in Nature Medicine. Bile, although made in the liver, is stored in the gall bladder and transported through ducts to the small intestine where it helps to digest fats. (source: uphs.upenn.edu)
|
